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Abstract
Left atrial myxomas are the most common type of benign primary cardiac tumor. Patients can present with generalized
symptoms, such as fatigue, symptoms from obstruction of the myxoma, or even embolization of the myxoma causing distal
thrombosis. We describe a case with several-month duration of syncopal episodes that occurred after coughing and with
exertion. Computed tomography of the chest showed a 6.1 cm by 4.5 cm mass in the left atrium, later evaluated with an
echocardiogram. Cardiothoracic surgery removed the mass, and it was determined to be an atrial myxoma. It is important
for an internist to be able to diagnose an atrial myxoma because of the risks associated with embolization and even sudden
death as myxoma can block blood supply from atrium to ventricle.
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Case Report
A 46-year-old male presented to the emergency department
with several-month duration of exertional dyspnea after taking only a few steps with subsequent nonproductive coughing episodes leading to syncopal events. These episodes
were ongoing over the past 8 months and had worsened over
the 2 months prior to presentation. The patient was unable to
work or drive for fear of coughing and suddenly losing consciousness. The patient also had 2-month duration of bilateral lower extremity edema, abdominal distension, and
generalized fatigue with diagnoses of portal venous thrombosis at the same time, with anticoagulation noncompliance.
On presentation during this admission, the patient’s vital
signs were within normal limits, and the patient was afebrile
and had an oxygen saturation of 97% on room air. Physical
exam was significant for an elevated jugular venous pressure, a loud S1, an early diastolic tumor plop but no murmurs, a positive hepatojugular reflux, and 1+ pedal edema in
bilateral lower extremities. Lungs were clear to auscultation
bilaterally. Pertinent laboratory work included a brain natriuretic peptide level of 1411 pg/mL and an erythrocyte sedimentation rate (ESR) of 12 mm/h.
In the emergency room, the patient underwent a computed
tomography (CT) of the chest (Figure 1), which demonstrated a 6.1 cm by 4.5 cm mass in the left atrium. A transthoracic echocardiogram with contrast was performed for
further evaluation. Left ventricular ejection fraction was
60% to 65%, and the right ventricle was moderately dilated

with moderate systolic dysfunction. The left atrium was
moderately enlarged and a massive echodensity occupied the
entire left atrium. Severe obstructive stenosis across the
mitral valve was suggested by the mean transmitral gradient.
The tricuspid valve showed moderate regurgitation with a jet
velocity suggestive of severe pulmonary hypertension.
Cardiac catheterization performed prior to surgery showed
mild nonobstructive coronary artery disease.
The patient underwent cardiothoracic surgery for removal of
the left atrial mass, which was subsequently determined to be a
left atrial myxoma. A transesophageal echocardiogram (Figure
2) was performed preoperatively and postoperatively.
Preoperative findings included the left atrial mass, which
appeared to be attached to the interatrial septum, biatrial enlargement, and a severely dilated and hypokinetic right ventricle.
Postoperative findings showed complete removal of the mass
and trivial mitral and tricuspid regurgitation. Histopathology
confirmed the diagnosis of the cardiac myxoma.
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Figure 1. CT chest of a large left atrial myxoma. Dimensions of the LA mass are 6.1 cm × 4.5 cm. We could not determine whether
the LA mass is a LA myxoma or a large thrombus on chest CT scan.

Figure 2. Transesophageal echocardiogram of the large obstructing left atrial myxoma. The dimensions of the LA myxoma were 6.1
cm × 4.5 cm and occupied most of the volume of the LA and caused severe obstructive stenosis across the mitral valve. The patient was
also found to have severe pulmonary hypertension (LA, left atrium; LV, left ventricle; MV, mitral valve).

The patient was discharged on postoperative day 3 with
the following medications: rivaroxaban, losartan, metoprolol tartrate, and aspirin, and the patient was to followup with a primary care provided and continue taking
rivaroxaban.
Hypercoagulability workup when not on anticoagulation
was significant for a low protein C level. The patient was
discharged home on long-term anticoagulation secondary to
portal vein thrombosis with protein C deficiency.

Epidemiology
Tumors that originate in the myocardium are rare, accounting for less than 0.1% of the population.1 Of the primary cardiac tumors, approximately 80% are considered benign, and
atrial myxomas account for approximately half of the benign
tumors.2 Papillary fibroelastomas and lipomas are other
types of benign cardiac tumors in adults, and rhabdomyomas
and fibromas are common pediatric cardiac tumors.3
Myxomas can vary in consistency but usually are composed
of a scattering of cells with a mucopolysaccharide stroma.4
Approximately 80% to 90% of myxomas occur in the left
atrium.5,6 The remainder of myxomas occur primarily in the
right atrium with a very rare amount (less than 2%) occurring
in the ventricles.7 Atrial myxomas are more common in

females,5,8 but males are more likely to have embolization as
a sequela of a myxoma.9

Signs and Symptoms
The production of signs and symptoms from a myxoma is
dependent on the location of the myxoma and include
embolization, obstruction of blood flow through the heart,
invasion of the tumor in surrounding myocardium and lung
tissue, and constitutional symptoms. Myxomas that originate from the left atrium and the aortic valve are at the
highest risk of embolization, which occur to the systemic
circulation.10 In patients with a left atrial myxoma, symptoms may include signs of systemic embolization, such as
cerebral emboli leading to neurological symptoms as well
as emboli to other organs leading to myocardial infarction,
renal failure, or mesenteric ischemia.11 Right atrial myxomas may lead to embolization into the pulmonic circulation
leading to symptoms of pulmonary embolism. Left atrial
tumors may also obstruct blood flow to the systemic circulation causing mitral valve regurgitation and heart failure
signs and symptoms and can lead to secondary pulmonary
hypertension.5,12 Myxomas may also lead to invasion of the
myocardium or the adjacent lung leading to arrhythmias,
pericardial effusion, or pulmonary symptoms.12,13
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Figure 3. Syncopal episode physiology.

Constitutional symptoms such as fatigue and weight loss
are common in 34% of patients.14

Evaluation
A cardiac tumor may be visualized on CT scan of the chest,
but it is difficult to differentiate a cardiac mass versus thrombus. Transthoracic echocardiography usually identifies the
mass, but transesophageal echocardiography often provides
better visualization of the left atrium and allows for clear differentiation of a tumor versus a thrombus by determining
whether the mass has a stalk and therefore is a tumor or is
unconnected from the intra-myocardial wall and therefore is
a thombus.15,16 An echocardiogram also provides information about the mass including whether it obstructs circulation. Cardiac magnetic resonance imaging is another option
for evaluating a cardiac tumor.17 Laboratory assessment
includes an elevated ESR or C-reactive protein (CRP), which
is thought to be due to an autoimmune component involving
interleukin-6.18,19 Elevated ESR and CRP occurs in approximately 40% of patients with myxoma and are more common
in patients with systemic symptoms.11

Treatment
Surgical removal is the best treatment option if possible, as
the risk of embolization is significant if the atrial myxoma is
left in place. The most concerning consequence of an atrial
myxoma is the risk of embolization and sudden death in up
to one third of patients; therefore, urgent surgical resection of
myxomas is recommended.20-22 Postoperative mortality after
resection is generally low at less than 5%,11 and the 20-year
survival rate is approximately 85%.22

Risk of Recurrence
Risk of recurrence is approximately 5%22 and is often more
common when the initial myxoma presentation is
multicentric.9

Discussion
The patient introduced in this case report had a unique presentation of a left atrial myxoma, although other cases of
atrial myxomas discovered after syncopal episodes have also

been reported in literature.23-25 Common presenting signs
and symptoms include generalized symptoms like fatigue
and weight loss, as well as cardiovascular symptoms. These
cardiovascular symptoms come from mitral valve obstruction and/or elevated left atrial pressure and include chest
pain, dyspnea on exertion, orthopnea, and paroxysmal nocturnal dyspnea.11,25-27 Other significant manifestations are
neurological deficits from embolization of the myxoma,
leading to events related to cerebral ischemia or infarction,27,28 retinal artery occlusion,29 and even sudden death.21
However, patients can also present asymptomatically or with
minimal cardiac symptoms.24
The patient in this case report endorsed generalized
fatigue and symptoms of mitral valve obstruction including
dyspnea on exertion, loud S1, and a tumor plop (ie, an early
diastolic sound due to movement of the myxoma across the
mitral valve into the left ventricle). The patient’s frequent
syncopal episodes can be explained by the large left atrial
mass obstructing the outflow of blood to the brain and
thereby inducing syncopal events (see Figure 3). In addition,
the mitral valve obstruction causes a sudden increase in left
atrial pressure, causing the patient to cough.
The decision to provide anticoagulation to a patient after
successful removal of a cardiac myxoma is not well studied.
No clinical studies reviewing anticoagulation and long-term
outcomes have been published to date. Existing case reports
include anticoagulation when a patient initially presents with
a pulmonary embolism (PE) and a right atrial myxoma, as a
PE can reoccur in 0.4% to 5% of patients after right myxoma
resection.1,30 Causes of recurrent PE following surgical excision of the myxoma include incomplete surgical resection of
the myxoma and detachment of emboli during surgical
removal.1 In general, a patient is at a higher risk of recurrent
embolism if emboli are from multiple origins, if there is a
family history of myxomas (eg, Carney complex), or if the
myxoma reoccurs from progenitor cells.1 This is due to myxomatous tissue being typically friable and easily detachable
with ability to adhere to other sites, promoting embolization.1,31 The Carney complex consists of unusual skin pigmentation (lentigines), multiple myxomas in the heart and
throughout the body, and tumors in endocrine glands.32 It
accounts for 7% to 10% of cardiac myxomas.33 With the
Carney complex, the risk of recurrence of an atrial myxoma
is as high as 25%, whereas normal recurrence of the atrial
myxoma is generally 1% to 3%.34 The risk and clinical
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manifestations of embolization depend on which chamber
the atrial myxoma resides. With left atrial myxomas, embolism occurs in 30% to 45% of patients, and usually to the
brain or kidneys. With right atrial myxomas, embolism
occurs in 10% of patients, and these can lead to PE.1,34
Regardless, left atrial myxoma can cause positional symptoms such as paroxysmal nocturnal dyspnea, typical cardiac
murmur such as tumor plop, and can cause sudden cardiac
death as the worst scenario.35 A conglomeration of the aforementioned clinical symptoms and signs should raise a high
suspicion for early diagnosis of atrial myxoma.

Conclusion
Diagnosis of an atrial myxoma must be considered when a
patient is found to have cardiac mass and variable constitutional symptoms from outflow obstruction or embolization.
While primary cardiac tumors are rare, myxomas are the
most common type of cardiac tumor. Surgical removal is the
best option to avoid embolization and even sudden death.
Prognosis directly after surgery and long-term is good, and
myxoma recurrence is generally low. The need for long-term
anticoagulation is controversial and needs more research due
to the rarity of this condition.
Authors’ Note
This patient has been managed by the medicine team and has been
seen at the East Tennessee State University affiliated teaching
hospital.
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